New podcast Long Read – Two-component vaccines

In focus / 27 October 2020

Photo: iStock

Listen in to the latest Drug Safety Matters podcast Long Read about how to prevent medication errors with two-component vaccines.


Medication errors with vaccines can harm individual patients, but when they also undermine trust in public health programmes, serious problems can ripple across entire communities – as the Samoan healthcare crisis of 2018 dramatically showed. The Institute for Safe Medication Practices offers straightforward advice that could prevent those errors from happening again.

This episode is part of the Drug Safety Matters podcast Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Photo: iStock

Photo: iStock

You may also like


ISoP annual meeting looks to a new era of pharmacovigilance

ISoP’s 2022 annual meeting was themed “A New Era of Pharmacovigilance: Challenges and Opportunities”. Independent consultant Mary Stapleton shares her observations of the event.

In focus / 15 November 2022

Safety of HIV medications – new podcast out now

Henry Zakumumpa from Makerere University School of Public Health airs his research on HIV care and treatment strategies in Uganda and the need for more robust pharmacovigilance.

In focus / 04 May 2022

Advancing pharmacovigilance in Africa – new podcast episode

Eleni Aklillu and Abbie Barry of the PROFORMA project join the Drug Safety Matters podcast to discuss the strides made by PROFORMA in boosting safety surveillance in Africa.

In focus / 24 March 2022

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more